Matches in Wikidata for { <http://www.wikidata.org/entity/Q113941831> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q113941831 description "clinical trial" @default.
- Q113941831 description "ensayo clínico" @default.
- Q113941831 description "ensayu clínicu" @default.
- Q113941831 description "klinisch onderzoek" @default.
- Q113941831 description "клінічне випробування" @default.
- Q113941831 description "تجربة سريرية" @default.
- Q113941831 description "临床试验" @default.
- Q113941831 name "A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906" @default.
- Q113941831 type Item @default.
- Q113941831 label "A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906" @default.
- Q113941831 prefLabel "A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906" @default.
- Q113941831 P1050 Q113941831-4F17BADE-CB11-4CFF-A76A-BFC9F42DFB1C @default.
- Q113941831 P1132 Q113941831-617781EE-F28D-4162-93A4-5E1E503D94C6 @default.
- Q113941831 P1476 Q113941831-8387D930-8C99-4A99-9F00-F2BB19575CEF @default.
- Q113941831 P17 Q113941831-3CE3E854-8934-445E-9958-4D8278413563 @default.
- Q113941831 P17 Q113941831-8D51865E-35DA-4E16-8A18-1B7C31058843 @default.
- Q113941831 P17 Q113941831-B0ABA272-BC7C-4924-A9AA-1FFCA4BB78E1 @default.
- Q113941831 P17 Q113941831-CB5D2CDB-E11F-4C62-AD1E-CC28B9D75BF3 @default.
- Q113941831 P2899 Q113941831-7336CE16-4C5C-4E0B-9B64-6910625C8F00 @default.
- Q113941831 P3098 Q113941831-D8F6A15F-BE8C-4492-9091-075D481B5A23 @default.
- Q113941831 P31 Q113941831-4AC1C478-E1D1-442D-9B37-9FC9E6779F51 @default.
- Q113941831 P4135 Q113941831-9A0EE3E5-A138-4A9F-8329-0689E1F89DAD @default.
- Q113941831 P580 Q113941831-B896980F-B543-4CB9-BB3E-84FE35ABE895 @default.
- Q113941831 P582 Q113941831-E3254710-620C-4566-A533-57E378C628C5 @default.
- Q113941831 P6099 Q113941831-D9EFD3F4-F671-4B2D-AE85-B67140FB041B @default.
- Q113941831 P8005 Q113941831-4442D566-B6BC-40B5-9247-F76D09904C02 @default.
- Q113941831 P8363 Q113941831-955B7D84-8CA3-4F60-AC6D-8EA60F0081C8 @default.
- Q113941831 P1050 Q332428 @default.
- Q113941831 P1132 "+80" @default.
- Q113941831 P1476 "A Non-randomised, Open-label, 2-part, Parallel-cohort Trial to Evaluate 1) Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of BI 456906 in Patients With Cirrhosis and Varying Degrees of Hepatic Impairment Relative to Healthy Subjects With and Without Overweight/Obesity and 2) Safety and Tolerability of Multiple Subcutaneous Doses of BI 456906 in Patients With Overweight/Obesity With Cirrhosis and Varying Degrees of Hepatic Impairment Relative to Patients With Overweight/Obesity Without Cirrhosis/Hepatic Impairment" @default.
- Q113941831 P17 Q183 @default.
- Q113941831 P17 Q28 @default.
- Q113941831 P17 Q30 @default.
- Q113941831 P17 Q664 @default.
- Q113941831 P2899 "+18" @default.
- Q113941831 P3098 "NCT05296733" @default.
- Q113941831 P31 Q30612 @default.
- Q113941831 P4135 "+75" @default.
- Q113941831 P580 "2022-04-27T00:00:00Z" @default.
- Q113941831 P582 "2023-08-24T00:00:00Z" @default.
- Q113941831 P6099 Q5452194 @default.
- Q113941831 P8005 Q76649708 @default.
- Q113941831 P8363 Q78089383 @default.